Immunology/Inflammation(免疫及炎症)
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
Products for Immunology/Inflammation
- 5-Lipoxygenase(10)
- Papain(1)
- PGDS(1)
- PGE synthase(24)
- SIKs(10)
- IκB/IKK(63)
- AP-1(3)
- KEAP1-Nrf2(63)
- NOD1(1)
- TLR(125)
- NF-κB(226)
- Interleukin Related(144)
- 15-lipoxygenase(2)
- Others(63)
- Aryl Hydrocarbon Receptor(32)
- CD73(14)
- Complement System(51)
- Galectin(10)
- IFNAR(21)
- NO Synthase(73)
- NOD-like Receptor (NLR)(45)
- STING(97)
- Reactive Oxygen Species(436)
- Apoptosis(631)
- FKBP(19)
- eNOS(5)
- iNOS(28)
- nNOS(20)
- Glutathione(52)
- Adaptive Immunity(206)
- Allergy(125)
- Arthritis(32)
- Autoimmunity(175)
- Gastric Disease(91)
- Immunosuppressants(36)
- Immunotherapeutics(4)
- Innate Immunity(552)
- Pulmonary Diseases(110)
- Reactive Nitrogen Species(49)
- Reactive Sulfur Species(26)
- Specialized Pro-Resolving Mediators(50)
- Cyclic GMP-AMP Synthase(2)
- Cat.No. 产品名称 Information
-
GC49005
2S-Eriodictyol
圣草酚; Huazhongilexone
A flavanone with antioxidant activity -
GC49003
(E)-Ajoene
NSC 614554
A disulfide with diverse biological activities -
GC49002
Sinigrin (hydrate)
黑芥子硫苷酸钾一水;芥子甙单水合物
A glucosinolate with diverse biological activities -
GC48998
β-Defensin-1 (human) (trifluoroacetate salt)
hBD-1
An antimicrobial peptide -
GC48996
Phenylacetyl-Coenzyme A (sodium salt)
Phenylacetyl-CoA
A key intermediate in aerobic catabolism of phenylacetate in bacteria -
GC48993
Protectin D1-d5
Neuroprotectin D1-d5, NPD1-d5, PD1-d5
An internal standard for the quantification of protectin D1 - GC48989 LTX-315 (trifluoroacetate salt) A synthetic cationic amphiphilic peptide
-
GC48988
Apramycin (sulfate hydrate)
Nebramycin II
An aminoglycoside antibiotic -
GC48987
UDP (sodium salt hydrate)
Uridine-5'-diphosphate
An agonist of P2Y6 -
GC48985
NF-κB Inhibitor (trifluoroacetate salt)
SN50 Peptide
A cell-permeable peptide that blocks nuclear import of NF-κB -
GC48984
Esomeprazole
埃索美拉唑镁,(S)-Omeprazole; (-)-Omeprazole
An H+/K+-ATPase inhibitor -
GC48974
Ac-VEID-AMC (ammonium acetate salt)
NAcetylValGluIleAsp7amido4Methylcoumarin, Caspase6 Substrate (Fluorogenic)
A caspase-6 fluorogenic substrate - GC48973 Sekikaic Acid A lichen metabolite with diverse biological activities
-
GC48972
Resolvin E2
(-)-Resolvin E2
A specialized pro-resolving mediator -
GC48971
AZD 1152 (hydrochloride)
5-[[7-[3-[乙基[2-(磷酰氧基)乙基]氨基]丙氧基]-4-喹唑啉基]氨基]-N-(3-氟苯基)-1H-吡唑-3-乙酰胺二盐酸盐
A prodrug for a potent Aurora B inhibitor -
GC19843
Nimbolide
印苦楝内酯
An anticancer phytochemical - GC62695 OP-5244 sodium OP-5244 sodium 是一种有效和具有口服活性的 CD73 抑制剂,IC50 值为 0.25 nM。OP-5244 sodium 通过阻断腺苷的产生来逆转免疫抑制作用,具有进行癌症研究的潜力。
- GC62694 OP-5244 OP-5244 是一种有效和具有口服活性的 CD73 抑制剂,IC50 值为 0.25 nM。OP-5244 通过阻断腺苷的产生来逆转免疫抑制作用,具有进行癌症研究的潜力。
- GC62693 SCR130 SCR130 is a novel DNA repair inhibitor with IC50s of 14 μM in Reh cells and 2 μM in Nalm6 cells. SCR130 specifically inhibits DNA Ligase IV‐mediated joining with minimal or no effect on Ligase III and Ligase I mediated joining.
-
GC62685
Guselkumab
古塞库单抗; CNTO 1959
Guselkumab 是一种重组人 IgG1 单克隆抗体,针对 IL-23p19 亚基。Guselkumab 与人和食蟹猴 IL-23 的结合值 Kd 分别为 3.3 pM 和 1.9 pM。Guselkumab 抑制 IL-23 信号通路下游细胞因子的产生,可用于银屑病关节炎的研究。 - GC62676 TJ191 TJ191 is a selective anti-cancer small molecule that targets low TβRIII-expressing malignant T-cell leukemia/lymphoma cells.
- GC62668 TLR7/8-IN-1 TLR7/8-IN-1 为 TLR7/TLR8 抑制剂的结晶形式,来自专利 WO2019220390,化合物 2b. TLR7/8-IN-1 可用于自身免疫性疾病的研究。
- GC62665 JAK2/FLT3-IN-1 TFA JAK2/FLT3-IN-1 (TFA) 是一种口服有效的双重 JAK2/FLT3 抑制剂,对 JAK2,FLT3,JAK1 和 JAK3 的 IC50 分别为 0.7 nM,4 nM,26 nM 和 39 nM。JAK2/FLT3-IN-1 (TFA) 具有抗癌活性。
- GC62664 G140 G140 is a potent and selective inhibitor of cyclic GMP-AMP synthase (cGAS), with IC50s of 14.0?nM and 442?nM for h-cGAS and m-cGAS, respectively.
- GC62659 IL-17A inhibitor 1 IL-17A inhibitor 1 (example 24) 是 IL-17A 的抑制剂,其在alphalisa assay和HT-29 细胞中的 IC50 值分别为 <9.45 nM 和 9.3 nM。
- GC62657 MRIA9 MRIA9 是 ATP 竞争性的、pan-SIK 和 PAK2/3 抑制剂,其对 SIK1、SIK2 和 SIK3 的 IC50 值分别为 516 nM, 180 nM 和 127 nM。
-
GC62654
GSK778
iBET-BD1
GSK778 (iBET-BD1) is a strong BD1 bromodomain inhibitor of the BET proteins, with IC50 value of 75 nM for BRD2 BD1, 41 nM for BRD3 BD1, 41 nM for BRD4 BD1, and 143 nM for BRDT BD1. - GC62652 UZH1a UZH1a 是一种有效和选择性的 METTL3 抑制剂,IC50 值为 280 nM。UZH1a 可用于细胞进程的转录组调控。UZH1a 具有抗肿瘤活性。UZH1a 也可用作研究 METTL3 的化学探针。
- GC62641 WEHI-9625 WEHI-9625 是一种首创的,三环砜小分子凋亡抑制剂,EC50 值为 69 nM。WEHI-9625 与 VDAC2 结合可促进其抑制小鼠 BAK 诱导的细胞凋亡的能力,但对人 BAK 和与凋亡效应密切相关的 BAX 因子均完全无效。
- GC62640 APG-1387 APG-1387 是一种二价 SMAC 模拟物,是 IAP 拮抗剂,可阻断 IAP 家族蛋白 (XIAP,cIAP-1,cIAP-2 和 ML-IAP) 的活性。APG-1387 诱导 cIAP-1 和 XIAP 蛋白降解以及 caspase-3 激活和 PARP 裂解,从而导致细胞凋亡。APG-1387 可用于肝细胞癌,卵巢癌和鼻咽癌的研究。
-
GC62639
rel-Zotatifin
rel-eFT226
reli -Zotatifin是Zotatifin的外消旋异构体,作为eIF4A抑制剂,活性小于Zotatifin。Zotatifin (eFT226) 是一种有效,选择性和耐受性良好的 eIF4A 抑制剂。Zotatifin 可促进 eIF4A 与 5’-UTRs 中具有识别基序的特定 mRNA 序列结合 (IC50=2 nM),并干扰 eIF4F 起始复合物的组装。 -
GC62636
Resiquimod-d5
R848-d5; S28463-d5
Resiquimod-d5 (R848-d5) 是 Resiquimod 的氘代物。Resiquimod 是一种 TLR7/TLR8 的激动剂, 可诱导细胞因子如 TNF-α,IL-6 和 IFN-α 的上调。 - GC62633 GGTI-2154 GGTI-2154 是一种有效和选择性的 geranylgeranyltransferase I (GGTase I) 抑制剂,IC50 值为 21 nM。GGTI-2154 对 GGTase I 的选择性是 FTase (IC50=5600 nM) 的 200 倍以上。GGTI-2154 可用于癌症的研究。
-
GC62630
TAS-117 hydrochloride
TAS-117 hydrochloride
TAS-117 hydrochloride 是一种有效、选择性、具有口服活性的别构 Akt 抑制剂 (对 Akt1、2 和 3 的 IC50 分别为 4.8、1.6 和 44 nM)。TAS-117 hydrochloride 激发抗骨髓瘤活性并增强蛋白酶体抑制诱导的致命内质网应激。TAS-117 hydrochloride 诱导细胞凋亡 (apoptosis) 和自噬 (autophagy)。 - GC62626 ICCB-19 hydrochloride ICCB-19 hydrochloride is an inhibitor of TNFRSF1A Associated Via Death Domain (TRADD) with IC50 of 1.12 μM and 2.01 μM for protecting Velcade-induced apoptosis in Jurkat cells and protecting RDA in MEFs, respectively. ICCB-19 indirectly inhibits Receptor-interacting serine/threonine-protein kinase 1 (RIPK1). ICCB-19 effectively induces autophagy.
-
GC62621
Milademetan tosylate hydrate
DS-3032b; DS-3032 tosylate hydrate
Milademetan (DS-3032) tosylate hydrate 是特异性的、具有口服活性的 MDM2 抑制剂,用于急性髓系白血病和实体肿瘤的研究。Milademetan (DS-3032) tosylate hydrate 可诱导 G1 细胞周期阻滞、衰老和凋亡。 - GC62620 NHWD-870 NHWD-870 inhibits CSF1 expression through suppressing BRD4 and its target HIF1α.
- GC62615 AS-99 AS-99 是一流的、有效的、选择性的 ASH1L 组蛋白甲基转移酶抑制剂(IC50=0.79μ;M,Kd=0.89μ;M),具有抗白血病活性。 AS-99 阻断细胞增殖,诱导细胞凋亡和分化,下调 MLL 融合靶基因,并减少体内白血病负担。
- GC62609 E7766 disodium E7766 disodium 是一种大环桥连 STING 激动剂,Kd 为 40 nM。E7766 disodium 显示出强大的泛基因型和抗肿瘤活性。
- GC62608 E7766 diammonium salt E7766 diammonium salt, a macrocycle-bridged STING agonist with a Kd of 40 nM, shows potent pan-genotypic and antitumor activities.
- GC62598 MI-1061 TFA MI-1061 TFA 是一种有效的,口服可生物利用的,化学稳定性的 MDM2 (MDM2-p53 互作) 抑制剂 (IC50=4.4 nM; Ki=0.16 nM)。MI-1061 TFA 激活小鼠 SJSA-1 异种移植瘤组织中 p53 并诱导凋亡,具有抗肿瘤活性。
-
GC62596
CDK7-IN-3
7-(二甲基膦基)-3-[2-[[(3S)-6,6-二甲基-3-哌啶基]氨基]-5-(三氟甲基)-4-嘧啶基]-1H-吲哚-6-甲腈,CDK7-IN-3
CDK7-IN-3 (CDK7-IN-3) 是一种具有口服活性的高选择性非共价 CDK7 抑制剂,KD 为 0.065 nM。 CDK7-IN-3 对 CDK2 (Ki=2600 nM)、CDK9 (Ki=960 nM)、CDK12 (Ki=870 nM) 显示出较差的抑制作用。 CDK7-IN-3 诱导肿瘤细胞凋亡并具有抗肿瘤活性。 - GC62594 hnRNPK-IN-1 hnRNPK-IN-1 是一种异质核糖核蛋白 K (hnRNPK) 结合配体,用 SPR 和 MST 测量的 Kd 值分别为 4.6 μM 和 2.6 μM。hnRNPK-IN-1 通过破坏 hnRNPK 和 c-myc 启动子的结合来抑制 c-myc 转录。hnRNPK-IN-1诱导 Hela 细胞凋亡 (apoptosis),并具有很强的抗肿瘤活性。
- GC62590 E64FC26 E64FC26 是蛋白质二硫键异构酶 (PDI) 家族的一种有效的泛抑制剂,对 PDIA1、PDIA3、PDIA4、TXNDC5 和 PDIA6 的 IC50 分别为 1.9、20.9、25.9、16.3 和 25.4 μM。E64FC26 显示抗骨髓瘤活性。
- GC62586 IACS-8803 disodium IACS-8803 disodium 是一种高效环状二核苷酸的 STING 激动剂,具有强大的全身抗肿瘤作用。
-
GC62564
Mito-LND
Mito-Lonidamine
Mito-LND (Mito-Lonidamine) 是一种具有口服活性的且靶向线粒体的氧化磷酸化 (oxidative phosphorylation (OXPHOS)) 抑制剂。Mito-LND 抑制线粒体生物能,刺激活性氧 (reactive oxygen species) 的形成,并诱导肺癌细胞自噬细胞死亡。 - GC62562 EGFR-IN-11 EGFR-IN-11 是第四代 EGFR-酪氨酸激酶抑制剂 (EGFR-TKI),对三重突变的 EGFRL858R/T790M/C797S 的 IC50 为 18 nM。EGFR-IN-11 显著抑制 EGFR 磷酸化,诱导细胞凋亡,将细胞周期阻滞在 G0/G1处。
- GC62558 WDR5-IN-1 WDR5-IN-1 是一种有效的选择性 WD 重复结构域 5 (WDR5) 抑制剂,Kd 为 <0.02 nM。WDR5-IN-1 抑制 MLL1 组蛋白甲基转移酶活性 (HMT),IC50为 2.2 nM。WDR5-IN-1 减少 WDR5 移位基因的 MYC 募集,并在 CHP-134 (神经母细胞瘤) 和 Ramos (Burkitt淋巴瘤) 细胞系中显示出有效的抗增殖作用。
-
GC62554
S65487
VOB560
S65487 (VOB560) 是一种有效的选择性 Bcl-2 抑制剂。 S65487 对 BCL-2 突变也有活性,例如 G101V 和 D103Y。S65487 对 MCL-1,BFL-1 和 BCL-XL 的亲和力较差。S65487 诱导细胞凋亡 (apoptosis) 并具有抗癌活性。 -
GC62536
Bromelain
菠萝蛋白酶
A mixture of proteolytic enzymes